Clinical Trials
14
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903
- Conditions
- HIV Associated Lymphoma
- Interventions
- Biological: Bone Marrow Transplant
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2023-12-28
- Lead Sponsor
- Catherine Bollard
- Target Recruit Count
- 12
- Registration Number
- NCT04975698
- Locations
- 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸Georgetown, Washington, District of Columbia, United States
🇺🇸H. Lee Moffitt Cancer Center, Tampa, Florida, United States
Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST)
- Conditions
- HIV-Infected Individuals
- Interventions
- First Posted Date
- 2020-01-30
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Catherine Bollard
- Target Recruit Count
- 8
- Registration Number
- NCT04248192
- Locations
- 🇺🇸
Johns Hopkins University(Jhu), Baltimore, Maryland, United States
Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP)
- Conditions
- Congenital Heart Disease (CHD)
- Interventions
- First Posted Date
- 2020-01-22
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Catherine Bollard
- Target Recruit Count
- 17
- Registration Number
- NCT04236479
- Locations
- 🇺🇸
Children's National Health System, Washington, District of Columbia, United States
Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
- Conditions
- Hodgkin LymphomaDiffuse Large B Cell Lymphoma
- Interventions
- Biological: TAA-T cells
- First Posted Date
- 2019-02-18
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Catherine Bollard
- Target Recruit Count
- 18
- Registration Number
- NCT03843294
- Locations
- 🇺🇸
Utah University School of Medicine/Huntsman Cancer Institute, Salt Lake City, Utah, United States
Multi-antigen T Cell Infusion Against Neuro-oncologic Disease
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Catherine Bollard
- Target Recruit Count
- 33
- Registration Number
- NCT03652545
- Locations
- 🇺🇸
Brain Tumor Institute, Children's National Medical Center, Washington, District of Columbia, United States
- Prev
- 1
- 2
- 3
- Next